Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. - Wikidata - awgldk - TriplyDB

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

http://www.wikidata.org/entity/Q37191007

about

Adherens junction protein nectin-4 is the epithelial receptor for measles virus New viruses for cancer therapy: meeting clinical needs Potentiating cancer immunotherapy using an oncolytic virus Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses Retargeting Strategies for Oncolytic Herpes Simplex Viruses Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade Synthetic therapeutic gene circuits in mammalian cells Gene therapy on the move Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates Trial Watch:: Oncolytic viruses for cancer therapy Modification of mammalian reoviruses for use as oncolytic agents Synthetic genomics and synthetic biology applications between hopes and concerns Targeting tumor vasculature with an oncolytic virus.MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism Directed evolution of a virus exclusively utilizing human epidermal growth factor receptor as the entry receptor.Measles virus entry through the signaling lymphocyte activation molecule governs efficacy of mantle cell lymphoma radiovirotherapy.A proteoliposome containing apolipoprotein A-I mutant (V156K) enhances rapid tumor regression activity of human origin oncolytic adenovirus in tumor-bearing zebrafish and mice.Mechanisms of protein kinase PKR-mediated amplification of beta interferon induction by C protein-deficient measles virus Paramyxovirus entry and targeted vectors for cancer therapy.Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins.Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus.Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus Infection and killing of multiple myeloma by adenoviruses Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model Enhanced antitumor effects of an engineered measles virus Edmonston strain expressing the wild-type N, P, L genes on human renal cell carcinoma Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice.Self-assembled lipid nanomedicines for siRNA tumor targeting.Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68.Artificial riboswitches for gene expression and replication control of DNA and RNA viruses.The use of neural stem cells in cancer gene therapy: predicting the path to the clinic.A recombinant measles virus unable to antagonize STAT1 function cannot control inflammation and is attenuated in rhesus monkeys.Preclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.Encapsulation of semiconducting polymers in vault protein cages.Oncosuppressive suicide gene virotherapy "PVH1-yCD/5-FC" for pancreatic peritoneal carcinomatosis treatment: NFκB and Akt/PI3K involvement Oncolytic vesicular stomatitis virus induces apoptosis in U87 glioblastoma cells by a type II death receptor mechanism and induces cell death and tumor clearance in vivo Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice.Attenuated and protease-profile modified sendai virus vectors as a new tool for virotherapy of solid tumors.

P2860

Q24295305-BE9DF77B-CD47-4BBC-B7B2-23BBC2ED5216 Q24567699-FA63CD9E-AD8C-4818-9C08-94EFB5E9A25F Q24628810-3D0EB3C0-CB42-4F60-B906-5AE8B8B7A45A Q26745551-F50FED2B-1F4D-492C-A6E3-2937849699A4 Q26752807-25659670-F18A-4C53-B862-00EA82D2365B Q26765439-5F7F989D-2042-46CB-A631-744D5401C7DD Q26769977-1C1CDC94-FAA8-47BE-905D-0C296F16FA85 Q26826954-0E2DE810-E63D-4858-9F38-191CCF24C927 Q27007012-7BC87C0F-3A4F-4C7E-B919-B9C98B91B8D8 Q27007519-46D55501-647F-44CA-A2F4-4D131ACC8179 Q27021951-02A07901-FC54-4DAA-9689-05AF7E12A4CC Q28264900-CB46B0BC-4B09-4D22-8798-A9B7A5DFB05C Q28706666-E421ACF9-EBD9-4023-9C45-7D49CF38F077 Q30500348-809B01AC-A677-4267-AB7D-BD0A622D7A9E Q30502129-CC4CB317-62AA-4FEB-BDFA-DC493EE94CA8 Q30554270-22D41B66-678D-4C3E-ABB5-37F70399AA2A Q30557338-1E130B29-A487-4327-A9DE-F1C2ECBEE9EB Q30564011-EC65B3E3-2BC5-4FEF-BC53-80308D00B364 Q33558639-C5CB26EE-3EF4-439C-94E6-72E256A2D5B2 Q33619238-35F7F6E2-6D61-4892-9C14-E523F1242D37 Q33621028-105E7447-B19C-4C6E-A99B-7DCBB244D2C8 Q33622711-4DDA2AE1-41A0-40A2-A34A-7AD24D14B8C4 Q33690982-98723EEF-D852-4453-8988-3BD33813BB02 Q33691833-5DEEF3B0-82D6-4E85-A7C6-0D9E3D1C50ED Q33713048-D4025224-3FB4-4346-AD04-D51FB66BE05E Q33731148-3C3927C8-BAAC-49F0-82A8-0553D833A80E Q33772011-3C803EE0-13AD-4CA0-BC4B-311231C0AF28 Q33815701-D7541824-BCF2-4930-8EA9-6EA1C1AACFE3 Q33907953-42F59CB1-E6BE-4098-98CD-597727A8E372 Q33927165-252EBA3A-797F-441E-AB7E-1C5C8802685D Q33988096-F558571F-ADED-4C91-9D9A-A6F8C6FE58D0 Q34039619-4506E3CD-017F-4297-A784-0C61CF011335 Q34217778-7F8F53B2-45A2-4ED7-9413-306BA4660E88 Q34457823-E2B8E73E-C6E6-4F3A-AF69-8372C9D9025E Q34574879-ACF3DF54-A19B-4D1B-9666-9E386497C636 Q34611582-8573199F-08D6-438B-8E50-A7FAC6509718 Q34962518-0FA63B49-E3CB-4B08-994C-286FF1F6DB37 Q35077031-CB768F60-3DC3-4EC6-BEE9-AFB6ECDDED9E Q35110264-6B1EA626-7EBA-41E3-90ED-62AB546F11B8 Q35111983-5706887B-9797-4A9F-A64B-91E16A0564C5

P2860

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

http://www.wikidata.org/entity/Q37191007

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

@en

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

@nl

type

label

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

@en

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

@nl

prefLabel

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

@en

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

@nl

P1433

Q37191007-EB163C9E-A91C-4E98-BDB8-5DBDE28192D6

P1476

Q37191007-36FED1BE-E802-4156-9743-49D0E8E319A9

P2093

Q37191007-1F69FFF8-0BAA-4430-B2F0-DC581F74A3FA

Q37191007-2ECC8136-7C7D-42B4-9D19-47AF89A1FCD4

Q37191007-BD1BFB18-21D0-4B64-9D01-5F03C2ABAA10

P2860

Q37191007-02CE3E08-6C5C-4844-9FE8-BECA5ACEC869

Q37191007-03D57799-AA6B-4DB2-B517-817570B6DD80

Q37191007-048C4224-87DA-45C5-BC01-0DDE0EE3AD86

Q37191007-04F64DA9-95C1-4AF7-A2BE-FD6FD75F81BD

Q37191007-0547D2A3-8AEA-42A8-8509-BD7AF13F5DA3

Q37191007-07F5C388-B129-451C-AA6E-D1D9B5ADCB3C

Q37191007-081CE21F-DEBD-44A3-A5BE-508AEDD65005

Q37191007-0C46FA2D-8B9C-4481-81C9-B95D5984065A

Q37191007-0E886A8F-9F01-492E-A342-1EFF5D383ADA

Q37191007-1210DBA6-5FF7-430C-8B4A-7AF494413FDF

P2888

Q37191007-C5833150-51AB-4737-A27D-D96835EE00A7

P304

Q37191007-D3C362F3-6A86-4FBE-A934-F1F27ABD5719

P31

Q37191007-776E8B73-17EE-4D40-B1F3-A7B7F90710E5

P356

Q37191007-541D97CC-B9D0-4982-BCC3-235D4ECD66BE

P407

Q37191007-A9A606AF-3BD9-4CCA-B293-326013220B17

P433

Q37191007-9D1B4841-AA5B-4235-A949-7331AFBEF46E

P478

Q37191007-1EC76961-1CDE-4CAC-84CB-3FF8B64BE5E8

P50

Q37191007-96B195F9-3AD8-4EF9-9676-63F4630615B3

P577

Q37191007-BAFFA2F6-CDA9-4C7B-BCA6-DE0F4F773B38

P698

Q37191007-80A09F55-6409-4B1C-9463-C00C5503A5F0

P932

Q37191007-9E71615F-C3E0-421D-8D02-4CDF8A2F601F

P356

P1433

Nature Reviews Microbiology

P1476

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.

@en

P2093

Elena V Shashkova

http://www.w3.org/2001/XMLSchema#string

Michael A Barry

http://www.w3.org/2001/XMLSchema#string

Tanner Miest

http://www.w3.org/2001/XMLSchema#string

P2860

The human CD46 molecule is a receptor for measles virus (Edmonston strain)

Antiviral actions of interferons

Crystal structure of measles virus hemagglutinin provides insight into effective vaccines

ONCOLYTIC EFFECT OF POLIOMYELITIS VIRUS ON HUMAN EPIDERMOID CARCINOMA (HELA TUMOR) HETEROLOGOUSLY TRANSPLANTED TO GUINEA PIGS

How cells respond to interferons

SLAM (CDw150) is a cellular receptor for measles virus

A road map for those who don't know JAK-STAT

New functions for the matrix metalloproteinases in cancer progression

STATs and gene regulation

Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures

P2888

P304

529-540

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRMICRO1927

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Cattaneo

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18552863

http://www.w3.org/2001/XMLSchema#string

P932

3947522

http://www.w3.org/2001/XMLSchema#string